• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

DarioHealth launches iPhone-compatible glucose meter in Australia

January 19, 2018 By Sarah Faulkner

Dario Health

DarioHealth (NSDQ:DRIO) said today that the Lightning-enabled version of its blood glucose monitoring system is available in Australia.

The device is designed to connect with the latest Apple products, including the iPhone 7, iPhone 8 and iPhone X. The product’s launch comes just one month after it won approval from Australian authorities.

Israel-based DarioHealth reported that Apple iOS has more than 55% market share in Australia.

“We are happy to confirm that we are recommitting ourselves to the Australian market. Over the past few months, we have been working tirelessly to get the TGA (Therapeutic Goods Administration) Mark so we can cater to the Australian market and help people with diabetes to manage their disease with the most up-to-date technology Dario has to offer,” chairman & CEO Erez Raphael said in prepared remarks.

“We look forward to continuing our mission of simplifying diabetes management in all of our markets globally.”

The Dario Lightning-enabled device also launched in the U.K. this month. Next up for the company’s blood glucose monitoring system is the German market, according to DarioHealth.

The company’s Lightning-enabled product is still being reviewed by the FDA in the U.S., but DarioHealth said it expects to hear back from the regulatory agency over the next few months.

Want to stay on top of DDBN content? Sign up for our e-mail newsletter for a weekly dose of drug-device news.

Filed Under: Diabetes, Featured, mHealth (Mobile Health), Patient Monitoring, Pharmaceuticals Tagged With: dariohealth

IN CASE YOU MISSED IT

  • Senseonics stock is up as it sticks by revenue guidance
  • MedAlliance wins second FDA IDE nod for drug-coated balloon
  • Wells Fargo downgrades Tandem amid rise of automated insulin delivery competition
  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care

Reader Interactions

Comments

  1. Marina Lee says

    January 23, 2018 at 12:14 am

    I look for DarioHealth contact for further cooperation discussion
    Thanks

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS